Prophylactic treatment of a small child with severe factor VII deficiency using repeat dosing from a single vial of recombinant activated factor VII

Pediatric Blood and Cancer

Volumn 49, Issue 5, 2007, Pages 736-739

  Michaels, Lisa A ^a,b   Philipp, Claire S ^a   Eisele, Joan ^a   Pappas, Heather ^a   Saidi, Parvin ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

Bleeding disorders; Coagulation; Factor VII; NovoSeven; Pediatric

Indexed keywords

BLOOD CLOTTING FACTOR 7; PROPLEX T; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; UNCLASSIFIED DRUG; BLOOD CLOTTING FACTOR; PROTHROMBIN COMPLEX CONCENTRATES; RECOMBINANT FVIIA; RECOMBINANT PROTEIN;

ARTICLE; BLEEDING; BLOOD CLOTTING FACTOR 7 DEFICIENCY; CASE REPORT; CHILD; FEMALE; HUMAN; MULTIPLE DRUG DOSE; PRIORITY JOURNAL; PROPHYLAXIS; PROTHROMBIN TIME; COMPARATIVE STUDY; NEWBORN; PREMEDICATION;

BLOOD COAGULATION FACTORS; FACTOR VII; FACTOR VII DEFICIENCY; FEMALE; HEMORRHAGE; HUMANS; INFANT, NEWBORN; PREMEDICATION; RECOMBINANT PROTEINS;

EID: 35148880650     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20688     Document Type: Article

References (16)

1. Perry DJ. Factor VII deficiency. Br J Haematol 2002;118:689-700.
2. Ingerslev J, Kristensen HL. Clinical picture and treatment strategies in factor VII deficiency. Haemophilia 1998;4:689-696.
3. Ingerslev J, Knudsen L, Hvid I, et al. Use of recombinant factor VIIa in surgery in factor VII deficiency patients. Haemophilia 1997;3:215-218.
4. Mariani G, Testa MG, Di Paolantonio T, et al. Use of recombinant, activated factor VII in the treatment of congenital factor VII deficiencies. Vox Sang 1999;77:131-136.
5. Hunalt M, Bauer KA. Recombinant factor VIIa for the treatment of congenital factor VII deficiency. Semin Thromb Hemost 2000;26:401-405.
6. Holye S, Stuart R, Recht M. Prophylaxis of recurrent epistaxis and menorrhagia using recombinant factor VIIa in severe congenital factor VII deficiency. J Pediatr Hematol Oncol 2001;23:A14.
7. Karayalcin G, Hart D. Prophylaxis with FVIIa in a pediatric patient with severe factor VII deficiency. J Pediatr Hematol Oncol 2002;24:A30.
8. Tcheng WY, Donkin J, Konzal S, et al. Recombinant factor VIIa prophylaxis in a patient with severe congenital factor VII deficiency. Haemophilia 2004;10:295-298.
9. Mathijssen NCJ, Masereeuw R, Verbeek K, et al. Prophylactic effect of recombinant factor VIIa in factor VII deficient patients. Br J Haematol 2004;125:494-499.
10. Barnett JM, Demel KC, Mega AE, et al. Lack of bleeding in patients with severe factor VII deficiency. Am J Hematol 2005;78:134-137.
11. Giansily-Blaizot M, Al Dieri R, Schved JF. Thrombin generation measurement in factor VII-depleted plasmas compared to inherited factor VII-deficient plasmas. Pathophysiol Haemost Thromb 2003;33:36-41.
12. Nicolaisen EM. Antigenicity of activated recombinant factor VII followed through nine years of clinical experience. Blood Coagul Fibrinolysis 1998;9:S119-S123.
13. Koster T, Rosendaal FR, Reitsma PH, et al. Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms - the Leiden Thrombophilia Study (LETS). Thromb Haemost 1994;71:719-722.
14. Aledort LM. Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activity. J Thromb Haemost 2004;2:1700-1708.
15. Bonde C, Jensen B. Continuous infusion of recombinant activated factor VII: Stability in infusion pump systems. Blood Coagul Fibrinolysis 1998;9:S103-S105.
16. Schulman S, Bech Jensen M, Varon D, et al. Feasibility of using recombinant factor VIIa in continuous infusion. Thromb Haemost 1996;75:432-436.